Blossom Pediatric Nursing Home Profile
Key Indicators
- Authorised Capital ₹ 5.50 M
as on 16-11-2024
- Paid Up Capital ₹ 5.40 M
as on 16-11-2024
- Company Age 12 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 7.38 Cr
as on 16-11-2024
- Revenue 14.73%
(FY 2023)
- Profit -10.26%
(FY 2023)
- Ebitda -19.86%
(FY 2023)
- Net Worth 9.17%
(FY 2023)
- Total Assets -0.54%
(FY 2023)
About Blossom Pediatric Nursing Home
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.50 M and a paid-up capital of Rs 5.40 M.
The company currently has active open charges totaling ₹7.38 Cr.
Sandeep Yadav, Ashish Lothe, Ashish Akhuj, and Three other members serve as directors at the Company.
- CIN/LLPIN
U85191MH2012PTC238019
- Company No.
238019
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Nov 2012
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Nagpur, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Blossom Pediatric Nursing Home?
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chandrashekhar Namadeo  | Director | 10-May-2017 | Current |
| Sandeep Yadav | Director | 19-Nov-2012 | Current |
| Ashish Lothe | Director | 19-Nov-2012 | Current |
| Ashish Akhuj | Director | 02-Dec-2013 | Current |
| Harshal Ingole | Director | 02-Dec-2013 | Current |
| Yogesh Tembhekar | Director | 19-Nov-2012 | Current |
Financial Performance of Blossom Pediatric Nursing Home.
Blossom Pediatric Nursing Home Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 14.73% increase. The company also saw a substantial fall in profitability, with a 10.26% decrease in profit. The company's net worth moved up by a moderate rise of 9.17%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Blossom Pediatric Nursing Home?
In 2023, Blossom Pediatric Nursing Home had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Hch Pediatric And Neonatal Center Private LimitedActive 6 years 6 monthsSandeep Yadav, Ashish Lothe and 4 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 31 Mar 2017 | ₹7.38 Cr | Open |
How Many Employees Work at Blossom Pediatric Nursing Home?
Unlock and access historical data on people associated with Blossom Pediatric Nursing Home, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Blossom Pediatric Nursing Home, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Blossom Pediatric Nursing Home's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
